Position statement: Criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: An androgen excess society guideline

Journal of Clinical Endocrinology and Metabolism

Volumn 91, Issue 11, 2006, Pages 4237-4245

  Azziz, Ricardo ^a,l   Carmina, Enrico ^b   Dewailly, Didier ^c   Diamanti Kandarakis, Evanthia ^d   Escobar Morreale, Hector F ^e   Futterweit, Walter ^f   Janssen, Onno E ^g   Legro, Richard S ^h   Norman, Robert J ⁱ   Taylor, Ann E ^j   Witchel, Selma F ^k  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF PALERMO   (Italy)

^c LILLE UNIVERSITY HOSPITAL   (France)

^d UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^e UNIVERSITY OF ALCALÁ   (Spain)

^f MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^g UNIVERSITY OF DUISBURG ESSEN   (Germany)

^h PENN STATE COLLEGE OF MEDICINE   (United States)

ⁱ UNIVERSITY OF ADELAIDE   (Australia)

^j PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United States)

^k CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

^l CEDARS SINAI MEDICAL CENTER   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ACNE; ALOPECIA; CLINICAL FEATURE; CONSENSUS DEVELOPMENT; DIAGNOSTIC PROCEDURE; DISEASE CLASSIFICATION; HIRSUTISM; HUMAN; HYPERANDROGENISM; MENSTRUATION DISORDER; OVARY INSUFFICIENCY; OVARY POLYCYSTIC DISEASE; PHENOTYPE; PRIORITY JOURNAL; REVIEW; ARTICLE; CLASSIFICATION; CONSENSUS; FEMALE; MEDICAL SOCIETY; METABOLISM; PRACTICE GUIDELINE;

ANDROGEN;

ANDROGENS; CONSENSUS; FEMALE; GUIDELINES; HUMANS; HYPERANDROGENISM; POLYCYSTIC OVARY SYNDROME; SOCIETIES, MEDICAL;

EID: 33751526500     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2006-0178     Document Type: Article

References (97)

1. Stein I, Leventhal M 1935 Amenorrhoea associated with bilateral polycystic ovaries. Am J Obstet Gynecol 29:181-185
2. Balen A, Michelmore K 2002 What is polycystic ovary syndrome? Are national views important? Hum Reprod 17:2219-2227
3. Azziz R 2006 Controversy in clinical endocrinology: diagnosis of polycystic ovarian syndrome: the Rotterdam criteria are premature. J Clin Endocrinol Metab 91:781-785
4. Franks S 2006 Controversy in clinical endocrinology: diagnosis of polycystic ovarian syndrome: in defense of the Rotterdam criteria. J Clin Endocrinol Metab 91:786-789
5. Azziz R, Marin C, Hoq L, Badamgarav E, Song P 2005 Health care-related economic burden of the polycystic ovary syndrome during the reproductive life span. J Clin Endocrinol Metab 90:4650-4658
6. Kahsar-Miller MD, Nixon C, Boots LR, Go RC, Azziz R 2001 Prevalence of polycystic ovary syndrome (PCOS) in first-degree relatives of patients with PCOS. Fertil Steril 75:53-58
7. Legro RS, Bentley-Lewis R, Driscoll D, Wang SC, Dunaif A 2002 Insulin resistance in the sisters of women with polycystic ovary syndrome: association with hyperandrogenemia rather than menstrual irregularity. J Clin Endocrinol Metab 87:2128-2133
8. Yildiz BO, Yarali H, Oguz H, Bayraktar M 2003 Glucose intolerance, insulin resistance, and hyperandrogenemia in first degree relatives of women with polycystic ovary syndrome. J Clin Endocrinol Metab 88:2031-2036
9. Zawadski JK, Dunaif A 1992 Diagnostic criteria for polycystic ovary syndrome: towards a rational approach. In: Dunaif A, Givens JR, Haseltine FP, Merriam GR, eds. Polycystic ovary syndrome. Boston: Blackwell Scientific Publications; 377-384
10. ESHRE/ASRM 2004 Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 81:19-25
11. The Rotterdam ESHRE/ASRM-sponsored PCOS Consensus Workshop Group 2004 Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod 19:41-47
12. Aaron LA, Buchwald D 2001 A review of the evidence for overlap among unexplained clinical conditions. Ann Intern Med 134:868-881
13. Agency for Healthcare Research and Quality 2001 Defining and managing chronic fatigue syndrome. Summary, Evidence Report/Technology Assessment 42. Rockville, MD(http://www.ahrq.gov/clinic/epcsums/cfssum.htm)
14. Corazziari E 2004 Definition and epidemiology of functional gastrointestinal disorders. Best Pract Res Clin Gastroenterol 18:613-631
15. Feng Q, Zhou ZG, Tang WL, Yang XL, Long X 2005 [Comparison of 3 working definitions of metabolic syndrome in male medical examinees]. Zhong Nan Da Xue Xue Bao Yi Xue Ban 30:130-134
16. Ford ES, Giles WH 2003 A comparison of the prevalence of the metabolic syndrome using two proposed definitions. Diabetes Care 26:575-581
17. Hochberg MC 1997 Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 40:1725
18. Linder R, Dinser R, Wagner M, Krueger GR, Hoffmann A 2002 Generation of classification criteria for chronic fatigue syndrome using an artificial neural network and traditional criteria set. In Vivo 16:37-43
19. Marchesini G, Forlani G, Cerrelli F, Manini R, Natale S, Baraldi L, Ermini G, Savorani G, Zocchi D, Melchionda N 2004 WHO and ATPIII proposals for the definition of the metabolic syndrome in patients with type 2 diabetes. Diabet Med 21:383-387
20. Smith EL, Shmerling RH 1999 The American College of Rheumatology criteria for the classification of systemic lupus erythematosus: strengths, weaknesses, and opportunities for improvement. Lupus 8:586-595
21. Wiedermann FJ, Mayr A, Schobersberger W, Mutz N 1999 Definition and classification of the antiphospholipid syndrome. J Cardiovasc Surg (Torino) 40:919-920
22. Kahn R, Buse J, Ferrannini E, Stern M 2005 The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 28:2289-2304
23. Goldzieher JW, Axelrod LR 1963 Clinical and biochemical features of polycystic ovarian disease. Fertil Steril 14:631-653
24. Ferriman D, Purdie AW 1983 The aetiology of oligomenorrhoea and/or hirsuties: a study of 467 patients. Postgrad Med J 59:17-20
25. Falsetti L, Eleftheriou G 1996 Hyperinsulinemia in the polycystic ovary syndrome: a clinical, endocrine and echographic study in 240 patients. Gynecol Endocrinol 10:319-326
26. Khoury MY, Baracat EC, Pardini DP, Haidar MA, da Motta EL, de Lima GR 1996 Polycystic ovary syndrome: clinical and laboratory evaluation. Sao Paulo Med J 114:1222-1225
27. Azziz R, Waggoner WT, Ochoa T, Knochenhauer ES, Boots LR 1998 Idiopathic hirsutism: an uncommon cause of hirsutism in Alabama. Fertil Steril 70:274-278
28. Carmina E 1998 Prevalence of idiopathic hirsutism. Eur J Endocrinol 139:421-423
29. Talbott E, Clerici A, Berga SL, Kuller L, Guzick D, Detre K, Daniels T, Engberg RA 1998 Adverse lipid and coronary heart disease risk profiles in young women with polycystic ovary syndrome: results of a case-control study. J Clin Epidemiol 51:415-422
30. Alborzi S, Khodaee R, Parsanejad ME 2001 Ovarian size and response to laparoscopic ovarian electro-cauterization in polycystic ovarian disease. Int J Gynaecol Obstet 74:269-274
31. Williamson K, Gunn AJ, Johnson N, Milsom SR 2001 The impact of ethnicity on the presentation of polycystic ovarian syndrome. Aust NZ J Obstet Gynaecol 41:202-206
32. Amer SA, Li TC, Bygrave C, Sprigg A, Saravelos H, Cooke ID 2002 An evaluation of the inter-observer and intra-observer variability of the ultrasound diagnosis of polycystic ovaries. Hum Reprod 17:1616-1622
33. Haddad L, Evans JC, Gharani N, Robertson C, Rush K, Wiltshire S, Frayling TM, Wilkin TJ, Demaine A, Millward A, Hattersley AT, Conway G, Cox NJ, Bell GI, Franks S, McCarthy MI 2002 Variation within the type 2 diabetes susceptibility gene calpain-10 and polycystic ovary syndrome. J Clin Endocrinol Metab 87:2606-2610
34. Glueck CJ, Papanna R, Wang P, Goldenberg N, Sieve-Smith L 2003 Incidence and treatment of metabolic syndrome in newly referred women with confirmed polycystic ovarian syndrome. Metabolism 52:908-915
35. Orio Jr F, Matarese G, Di Biase S, Palomba S, Labella D, Sanna V, Savastano S, Zullo F, Colao A, Lombardi G 2003 Exon 6 and 2 peroxisome proliferator-activated receptor-gamma polymorphisms in polycystic ovary syndrome. J Clin Endocrinol Metab 88:5887-5892
36. Chang WY, Knochenhauer ES, Bartolucci AA, Azziz R 2005 Phenotypic spectrum of polycystic ovary syndrome: clinical and biochemical characterization of the three major clinical subgroups. Fertil Steril 83:1717-1723
37. Hahn S, Tan S, Elsenbruch S, Quadbeck B, Herrmann BL, Mann K, Janssen OE 2005 Clinical and biochemical characterization of women with polycystic ovary syndrome in North Rhine-Westphalia. Horm Metab Res 37:438-444
38. Azziz R, Woods KS, Reyna R, Key TJ, Knochenhauer ES, Yildiz BO 2004 The prevalence and features of the polycystic ovary syndrome in an unselected population. J Clin Endocrinol Metab 89:2745-2749
39. Azziz R, Sanchez LA, Knochenhauer ES, Moran C, Lazenby J, Stephens KC, Taylor K, Boots LR 2004 Androgen excess in women: experience with over 1000 consecutive patients. J Clin Endocrinol Metab 89:453-462
40. Conway GS, Honour JW, Jacobs HS 1989 Heterogeneity of the polycystic ovary syndrome: clinical, endocrine and ultrasound features in 556 patients. Clin Endocrinol (Oxf) 30:459-470
41. Balen AH, Conway GS, Kaltsas G, Techatrasak K, Manning PJ, West C, Jacobs HS 1995 Polycystic ovary syndrome: the spectrum of the disorder in 1741 patients. Hum Reprod 10:2107-2111
42. Legro RS, Myers ER, Barnhart HX, Carr BR, Carson SA, Diamond MP, Karr BA, Schlaff WD, Coutifaris C, McGovern PG, Cataldo NA, Steinkampf MP, Nestler JE, Gosman G, Giudice LC, Leppert PC, The pregnancy in polycystic ovary syndrome (PPCOS) study: baseline characteristics of the randomized cohort including racial effects. Fertil Steril, in press
43. Knochenhauer ES, Key TJ, Kahsar-Miller M, Waggoner W, Boots LR, Azziz R 1998 Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study. J Clin Endocrinol Metab 83:3078-3082
44. Kumar A, Woods KS, Bartolucci AA, Azziz R 2005 Prevalence of adrenal androgen excess in patients with the polycystic ovary syndrome (PCOS). Clin Endocrinol (Oxf) 62:644-649
45. Miller KK, Rosner W, Lee H, Hier J, Sesmilo G, Schoenfeld D, Neubauer G, Klibanski A 2004 Measurement of free testosterone in normal women and women with androgen deficiency: comparison of methods. J Clin Endocrinol Metab 89:525-533
46. Vermeulen A, Verdonck L, Kaufman JM 1999 A critical evaluation of simple methods for the estimation of free testosterone in serum. J Clin Endocrinol Metab 84:3666-3672
47. Van Uytfanghe K, Stockl D, Kaufman JM, Fiers T, De Leenheer A, Thienpont LM 2005 Validation of 5 routine assays for serum free testosterone with a candidate reference measurement procedure based on ultrafiltration and isotope dilution-gas chromatography-mass spectrometry. Clin Biochem 38:253-261
48. Kiddy DS, Sharp PS, White DM, Scanlon MF, Mason HD, Bray CS, Polson DW, Reed MJ, Franks S 1990 Differences in clinical and endocrine features between obese and non-obese subjects with polycystic ovary syndrome: an analysis of 263 consecutive cases. Clin Endocrinol (Oxf) 32:213-220
49. Rajkhowa M, Talbot JA, Jones PW, Pettersson K, Haavisto AM, Huhtaniemi I, Clayton RN 1995 Prevalence of an immunological LH beta-subunit variant in a UK population of healthy women and women with polycystic ovary syndrome. Clin Endocrinol (Oxf) 43:297-303
50. Norman RJ, Masters SC, Hague W, Beng C, Pannall P, Wang JX 1995 Metabolic approaches to the subclassification of polycystic ovary syndrome. Fertil Steril 63:329-335
51. DeUgarte CM, Woods KS, Bartolucci AA, Azziz R 2006 Degree of facial and body terminal hair growth in unselected black and white women: toward a populational definition of hirsutism. J Clin Endocrinol Metab 91:1345-1350
52. Ferriman D, Gallwey JD 1961 Clinical assessment of body hair growth in women. J Clin Endocrinol Metab 21:1440-1447
53. Wijeyaratne CN, Balen AH, Barth JH, Belchetz PE 2002 Clinical manifestations and insulin resistance (IR) in polycystic ovary syndrome (PCOS) among South Asians and Caucasians: is there a difference? Clin Endocrinol (Oxf) 57:343-350
54. Cunliffe WJ, Gould DJ 1979 Prevalence of facial acne vulgaris in late adolescence and in adults. Br Med J 1:1109-1110
55. Dalgard F, Svensson A, Holm JO, Sundby J 2004 Self-reported skin morbidity in Oslo. Associations with sociodemographic factors among adults in a crosssectional study. Br J Dermatol 151:452-457
56. Galobardes B, Davey Smith G, Jefferys M, McCarron P 2005 Has acne increased? Prevalence of acne history among university students between 1948 and 1968. The Glasgow Alumni Cohort Study. Br J Dermatol 152:824-825
57. Johnson MT, Roberts J 1978 Skin conditions and related need for medical care among persons 1-74 years. United States, 1971-1974. Vital Health Stat 11:i-v, 1-72
58. Rea JN, Newhouse ML, Halil T 1976 Skin disease in Lambeth. A community study of prevalence and use of medical care. Br J Prev Soc Med 30:107-114
59. Futterweit W, Dunaif A, Yeh HC, Kingsley P 1988 The prevalence of hyperandrogenism in 109 consecutive female patients with diffuse alopecia. JAm Acad Dermatol 19:831-836
60. O'Driscoll JB, Mamtora H, Higginson J, Pollock A, Kane J, Anderson DC 1994 A prospective study of the prevalence of clear-cut endocrine disorders and polycystic ovaries in 350 patients presenting with hirsutism or androgenic alopecia. Clin Endocrinol (Oxf) 41:231-236
61. Cela E, Robertson C, Rush K, Kousta E, White DM, Wilson H, Lyons G, Kingsley P, McCarthy MI, Franks S 2003 Prevalence of polycystic ovaries in women with androgenic alopecia. Eur J Endocrinol 149:439-442
62. Ardaens Y, Robert Y, Lemaitre L, Fossati P, Dewailly D 1991 Polycystic ovarian disease: contribution of vaginal endosonography and reassessment of ultrasonic diagnosis. Fertil Steril 55:1062-1068
63. van Santbrink EJ, Hop WC, Fauser BC 1997 Classification of normogonadotropic infertility: polycystic ovaries diagnosed by ultrasound versus endocrine characteristics of polycystic ovary syndrome. Fertil Steril 67:452-458
64. Laven JS, Imani B, Eijkemans MJ, de Jong FH, Fauser BC 2001 Absent biologically relevant associations between serum inhibin B concentrations and characteristics of polycystic ovary syndrome in normogonadotrophic anovulatory infertility. Hum Reprod 16:1359-1364
65. Jonard S, Robert Y, Cortet-Rudelli C, Pigny P, Decanter C, Dewailly D 2003 Ultrasound examination of polycystic ovaries: is it worth counting the follicles? Hum Reprod 18:598-603
66. Carmina E, Orio F, Palomba S, Longo RA, Lombardi G, Lobo RA 2005 Ovarian size and blood flow in women with polycystic ovary syndrome and their correlations with endocrine parameters. Fertil Steril 84:413-419
67. Jonard S, Robert Y, Dewailly D 2005 Revisiting the ovarian volume as a diagnostic criterion for polycystic ovaries. Hum Reprod 20:2893-2898
68. Balen AH, Laven JS, Tan SL, Dewailly D 2003 Ultrasound assessment of the polycystic ovary: international consensus definitions. Hum Reprod Update 9:505-514
69. Farquhar CM, Birdsall M, Manning P, Mitchell JM 1994 Transabdominal versus transvaginal ultrasound in the diagnosis of polycystic ovaries in a population of randomly selected women. Ultrasound Obstet Gynecol 4:54-59
70. Luciano AA, Chapler FK, Sherman BM 1984 Hyperprolactinemia in polycystic ovary syndrome. Fertil Steril 41:719-725
71. Moran C, Tapia MC, Hernandez E, Vazquez G, Garcia-Hernandez E, Bermudez JA 1994 Etiological review of hirsutism in 250 patients. Arch Med Res 25:311-314
72. Romaguera J, Moran C, Diaz-Montes TP, Hines GA, Cruz RI, Azziz R 2000 Prevalence of 21-hydroxylase-deficient nonclassic adrenal hyperplasia and insulin resistance among hirsute women from Puerto Rico. Fertil Steril 74:59-62
73. Escobar-Morreale HF 2004 Macroprolactinemia in women presenting with hyperandrogenic symptoms: Implications for the management of polycystic ovary syndrome. Fertil Steril 82:1697-1699
74. Janssen OE, Mehlmauer N, Hahn S, Offner AH, Gartner R 2004 High prevalence of autoimmune thyroiditis in patients with polycystic ovary syndrome. Eur J Endocrinol 150:363-369
75. Glintborg D, Henriksen JE, Andersen M, Hagen C, Hangaard J, Rasmussen PE, Schousboe K, Hermann AP 2004 Prevalence of endocrine diseases and abnormal glucose tolerance tests in 340 Caucasian premenopausal women with hirsutism as the referral diagnosis. Fertil Steril 82:1570-1579
76. Carmina E, Rosato F, Janni A, Rizzo M, Longo RA 2006 Extensive clinical experience: relative prevalence of different androgen excess disorders in 950 women referred because of clinical hyperandrogenism. J Clin Endocrinol Metab 91:2-6
77. Azziz R, Carmina E, Sawaya ME 2000 Idiopathic hirsutism. Endocr Rev 21:347-362
78. Wild RA, Vesely S, Beebe L, Whitsett T, Owen W 2005 Ferriman Gallwey self-scoring I: performance assessment in women with polycystic ovary syndrome. J Clin Endocrinol Metab 90:4112-4114
79. Carmina E, Wong L, Chang L, Paulson RJ, Sauer MV, Stanczyk FZ, Lobo RA 1997 Endocrine abnormalities in ovulatory women with polycystic ovaries on ultrasound. Hum Reprod 12:905-909
80. Carmina E, Lobo RA 1999 Do hyperandrogenic women with normal menses have polycystic ovary syndrome? Fertil Steril 71:319-322
81. Dewailly D, Catteau-Jonard S, Reyss AC, Leroy M, Pigny P 2006 Oligoanovulation with polycystic ovaries but not overt hyperandrogenism. J Clin Endocrinol Metab 91:3922-3927
82. Robinson S, Kiddy D, Gelding SV, Willis D, Niththyananthan R, Bush A, Johnston DG, Franks S 1993 The relationship of insulin insensitivity to menstrual pattern in women with hyperandrogenism and polycystic ovaries. Clin Endocrinol (Oxf) 39:351-355
83. Carmina E, Koyama T, Chang L, Stanczyk FZ, Lobo RA 1992 Does ethnicity influence the prevalence of adrenal hyperandrogenism and insulin resistance in polycystic ovary syndrome? Am J Obstet Gynecol 167:1807-1812
84. Legro RS, Finegood D, Dunaif A 1998 A fasting glucose to insulin ratio is a useful measure of insulin sensitivity in women with polycystic ovary syndrome. J Clin Endocrinol Metab 83:2694-2698
85. Legro RS, Kunselman AR, Dodson WC, Dunaif A 1999 Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women. J Clin Endocrinol Metab 84:165-169
86. Diamanti-Kandarakis E, Kouli CR, Bergiele AT, Filandra FA, Tsianateli TC, Spina GG, Zapanti ED, Bartzis MI 1999 A survey of the polycystic ovary syndrome in the Greek island of Lesbos: hormonal and metabolic profile. J Clin Endocrinol Metab 84:4006-4011
87. Ehrmann DA, Barnes RB, Rosenfield RL, Cavaghan MK, Imperial J 1999 Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome. Diabetes Care 22:141-146
88. Silfen ME, Denburg MR, Manibo AM, Lobo RA, Jaffe R, Ferin M, Levine LS, Oberfield SE 2003 Early endocrine, metabolic, and sonographic characteristics of polycystic ovary syndrome (PCOS): comparison between nonobese and obese adolescents. J Clin Endocrinol Metab 88:4682-4688
89. San Millan JL, Corton M, Villuendas G, Sancho J, Peral B, Escobar-Morreale HF 2004 Association of the polycystic ovary syndrome with genomic variants related to insulin resistance, type 2 diabetes mellitus, and obesity. J Clin Endocrinol Metab 89:2640-2646
90. Gambineri A, Pelusi C, Manicardi E, Vicennati V, Cacciari M, Morselli-Labate AM, Pagotto U, Pasquali R 2004 Glucose intolerance in a large cohort of Mediterranean women with polycystic ovary syndrome: phenotype and associated factors. Diabetes 53:2353-2358
91. Apridonidze T, Essah PA, Iuorno MJ, Nestler JE 2005 Prevalence and characteristics of the metabolic syndrome in women with polycystic ovary syndrome. J Clin Endocrinol Metab 90:1929-1935
92. Dokras A, Bochner M, Hollinrake E, Markham S, Vanvoorhis B, Jagasia DH 2005 Screening women with polycystic ovary syndrome for metabolic syndrome. Obstet Gynecol 106:131-137
93. Carmina E, Chu MC, Longo RA, Rini GB, Lobo RA 2005 Phenotypic variation in hyperandrogenic women influences the findings of abnormal metabolic and cardiovascular risk parameters. J Clin Endocrinol Metab 90:2545-2549
94. Ehrmann DA, Liljenquist DR, Kasza K, Azziz R, Legro RS, Ghazzi MN 2006 Prevalence and predictors of the metabolic syndrome in women with polycystic ovary syndrome. J Clin Endocrinol Metab 91:48-53
95. Michelmore K, Ong K, Mason S, Bennett S, Perry L, Vessey M, Balen A, Dunger D 2001 Clinical features in women with polycystic ovaries: relationships to insulin sensitivity, insulin gene VNTR and birth weight. Clin Endocrinol (Oxf) 55:439-446
96. Legro RS, Chiu P, Kunselman AR, Bentley CM, Dodson WC, Dunaif A 2005 Polycystic ovaries are common in women with hyperandrogenic chronic anovulation but do not predict metabolic or reproductive phenotype. J Clin Endocrinol Metab 90:2571-2579
97. Norman RJ, Hague WM, Masters SC, Wang XJ 1995 Subjects with polycystic ovaries without hyperandrogenaemia exhibit similar disturbances in insulin and lipid profiles as those with polycystic ovary syndrome. Hum Reprod 10:2258-2261